Norbert Grzasko
4PUBLICATIONS
30CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Jun 06, 2025
Phase III Trial of Pirtobrutinib Versus Idelalisib/Rituximab or Bendamustine/Rituximab in Covalent Bruton Tyrosine Kinase Inhibitor-Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN CLL-321).Jeff P Sharman, Talha Munir, Sebastian Grosicki
|Apr 23, 2025
Awareness and Knowledge About Preventive Vaccinations Among Patients with Hematological Malignancies.Marta Morawska, Marta Masternak, Norbert Grząśko
|Oct 17, 2024
A phase 1b/2 study evaluating efficacy and safety of MP0250, a designed ankyrin repeat protein (DARPin) simultaneously targeting vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF), in combination with bortezomib and dexamethasone, in patients with relapsed or refractory multiple myeloma.Stefan Knop, Monika Szarejko, Norbert Grząśko
|Jun 11, 2021
Final Overall Survival Analysis of the TOURMALINE-MM1 Phase III Trial of Ixazomib, Lenalidomide, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma.Paul G Richardson, Shaji K Kumar, Tamás Masszi
Pageof 1
Frequent Collaborators
1 joint publications
Paul G Richardson
1 joint publications
Shaji K Kumar
1 joint publications
Nizar J Bahlis
1 joint publications
Irwindeep Sandhu
1 joint publications
Cyrille Touzeau
1 joint publications
Jacob P Laubach
1 joint publications
Stefan Knop
1 joint publications
Karolin Trautmann-Grill
1 joint publications
Angelo Vacca
1 joint publications
Cyrus Khandanpour
